Page last updated: 2024-09-03

stachydrine and Cardiac Remodeling, Ventricular

stachydrine has been researched along with Cardiac Remodeling, Ventricular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, H; Guo, W; Hu, P; Lu, R; Shan, X; Tian, J; Wang, S; Wu, Q; Xu, M; Zhang, C; Zhao, P; Zheng, J1
Guo, W; Liao, YL; Lu, R; Shan, XL; Wei, HC; Zhang, C; Zhao, P1

Other Studies

2 other study(ies) available for stachydrine and Cardiac Remodeling, Ventricular

ArticleYear
Stachydrine hydrochloride suppresses phenylephrine-induced pathological cardiac hypertrophy by inhibiting the calcineurin/nuclear factor of activated T-cell signalling pathway.
    European journal of pharmacology, 2020, Sep-15, Volume: 883

    Topics: Animals; Calcineurin; Cells, Cultured; Disease Models, Animal; Gene Expression Regulation; Hypertrophy, Left Ventricular; Mice, Inbred C57BL; Myocytes, Cardiac; NFATC Transcription Factors; Phenylephrine; Proline; Rats, Wistar; Signal Transduction; Ventricular Function, Left; Ventricular Remodeling

2020
Effects of stachydrine on norepinephrine-induced neonatal rat cardiac myocytes hypertrophy and intracellular calcium transients.
    BMC complementary and alternative medicine, 2014, Dec-08, Volume: 14

    Topics: Animals; Animals, Newborn; Calcium; Heart; Heart Diseases; Hypertrophy; Leonurus; Male; Myocytes, Cardiac; Norepinephrine; Phosphorylation; Phytotherapy; Plant Extracts; Proline; Rats, Wistar; Signal Transduction; Ventricular Remodeling

2014